{"id":"NCT01180400","sponsor":"AstraZeneca","briefTitle":"A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder","officialTitle":"A Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Phase III Efficacy and Safety Study of TC-5214 (S-mecamylamine) in Flexible Doses as an Adjunct to an Antidepressant in Patients With Major Depressive Disorder Who Exhibit an Inadequate Response to Antidepressant Therapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-09","primaryCompletion":"2011-09","completion":"2011-09","firstPosted":"2010-08-12","resultsPosted":"2012-11-20","lastUpdate":"2014-04-11"},"enrollment":295,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Major Depressive Disorder","Depression"],"interventions":[{"type":"DRUG","name":"TC-5214","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"TC-5214","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to determine if TC-5214 or placebo (a tablet that looks like medicine tablet or capsule, but contains no active medicine) is safe and effective when taken together with another antidepressant.","primaryOutcome":{"measure":"Change in the Montgomery-Asberg Depression Rating Scale (MADRS) Total Score From Randomization to End of Treatment.","timeFrame":"Randomization (Week 8) to end of treatment (Week 16)","effectByArm":[{"arm":"TC-5214","deltaMin":-11.7,"sd":0.71},{"arm":"Placebo","deltaMin":-11.6,"sd":0.7}],"pValues":[{"comp":"OG000 vs OG001","p":"0.944"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":3},"locations":{"siteCount":66,"countries":["Czechia","Estonia","Finland","France","Germany","Hungary","Latvia","Lithuania","Poland","Sweden"]},"refs":{"pmids":["24507016"],"seeAlso":["http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=1412&filename=CSR-D4130C00003.pdf","http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_7111&studyid=1412&filename=D4130C00003_Revised_CSP_1_REDACTED.PDF"]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":147},"commonTop":["Headache","Orthostatic Hypotension","Constipation","Nausea","Dry Mouth"]}}